Published in Eur J Pediatr on October 01, 2001
Development of type 1 diabetes despite severe hereditary B-lymphocyte deficiency. N Engl J Med (2001) 3.85
Immunophenotyping of blood lymphocytes in childhood. Reference values for lymphocyte subpopulations. J Pediatr (1997) 3.80
Increased cell division but not thymic dysfunction rapidly affects the T-cell receptor excision circle content of the naive T cell population in HIV-1 infection. Nat Med (2000) 3.70
Enhancement of LFA-1-mediated cell adhesion by triggering through CD2 or CD3 on T lymphocytes. Nature (1989) 3.36
The gene encoding the epsilon subunit of the T3/T-cell receptor complex maps to chromosome 11 in humans and to chromosome 9 in mice. Proc Natl Acad Sci U S A (1987) 2.91
Efficacy and safety of gemtuzumab ozogamicin in patients with CD33-positive acute myeloid leukemia in first relapse. J Clin Oncol (2001) 2.71
Dying for a cause: NETosis, mechanisms behind an antimicrobial cell death modality. Cell Death Differ (2011) 2.60
Site-specific deletions involving the tal-1 and sil genes are restricted to cells of the T cell receptor alpha/beta lineage: T cell receptor delta gene deletion mechanism affects multiple genes. J Exp Med (1993) 2.23
E2A and EBF act in synergy with the V(D)J recombinase to generate a diverse immunoglobulin repertoire in nonlymphoid cells. Mol Cell (2000) 1.99
T cell receptor excision circles as markers for recent thymic emigrants: basic aspects, technical approach, and guidelines for interpretation. J Mol Med (Berl) (2001) 1.86
Flow cytometric analysis of normal B cell differentiation: a frame of reference for the detection of minimal residual disease in precursor-B-ALL. Leukemia (1999) 1.83
Predictors of health-related quality of life in children and adolescents with juvenile idiopathic arthritis: results from a Web-based survey. Arthritis Care Res (Hoboken) (2012) 1.73
Real-time quantitative PCR for the detection of minimal residual disease in acute lymphoblastic leukemia using junctional region specific TaqMan probes. Leukemia (1998) 1.68
Flow cytometric analysis of the Vbeta repertoire in healthy controls. Cytometry (2000) 1.66
Functional characterization of mitochondria in neutrophils: a role restricted to apoptosis. Cell Death Differ (2004) 1.65
Distinct molecular forms of human T cell receptor gamma/delta detected on viable T cells by a monoclonal antibody. J Exp Med (1988) 1.62
Suitable DNA isolation method for the detection of minimal residual disease by PCR techniques. Leukemia (1999) 1.61
Vascular endothelial growth factor gene haplotypes in Kawasaki disease. Arthritis Rheum (2006) 1.59
Unique selection determinant in polyclonal V delta 2-J delta 1 junctional regions of human peripheral gamma delta T lymphocytes. J Immunol (1994) 1.54
Molecular and flow cytometric analysis of the Vbeta repertoire for clonality assessment in mature TCRalphabeta T-cell proliferations. Blood (2001) 1.52
[Immunology in medical practice. XXXV. Screening of suspected immunodeficiency: diagnostic protocols for patients with opportunistic or recurrent severe infections, wasting and failure to thrive]. Ned Tijdschr Geneeskd (2000) 1.50
[Widely divergent clinical phenotype of x-linked agammaglobulinemia in two cousins]. Ned Tijdschr Geneeskd (2004) 1.44
Minimal residual disease in leukaemia patients. Lancet Oncol (2001) 1.43
Invasive Aspergillus infection in chronic granulomatous disease: treatment with itraconazole. J Pediatr (1989) 1.39
Neutrophil and monocyte adherence to and migration across monolayers of cytokine-activated endothelial cells: the contribution of CD18, ELAM-1, and VLA-4. Blood (1991) 1.37
Preferential rearrangements of the T cell receptor-delta-deleting elements in human T cells. J Immunol (1997) 1.36
Intravenous immunoglobulins--understanding properties and mechanisms. Clin Exp Immunol (2009) 1.34
CD18 activation epitopes induced by leukocyte activation. J Immunol (2001) 1.34
Heteroduplex PCR analysis of rearranged T cell receptor genes for clonality assessment in suspect T cell proliferations. Leukemia (1997) 1.33
Apoptosis of neutrophils. Acta Haematol (2004) 1.32
Precursor-B-ALL with D(H)-J(H) gene rearrangements have an immature immunogenotype with a high frequency of oligoclonality and hyperdiploidy of chromosome 14. Leukemia (2001) 1.28
Human immunodeficiency virus infection studied in CD4-expressing human-murine T-cell hybrids. Virology (1989) 1.26
Antibody L26 recognizes an intracellular epitope on the B-cell-associated CD20 antigen. Am J Pathol (1990) 1.26
TCR gene rearrangements and expression of the pre-T cell receptor complex during human T-cell differentiation. Blood (1999) 1.22
The Bruton's tyrosine kinase gene is expressed throughout B cell differentiation, from early precursor B cell stages preceding immunoglobulin gene rearrangement up to mature B cell stages. Eur J Immunol (1993) 1.21
Therapeutic efficacy of intravenous immunoglobulin preparations depends on the immunoglobulin G dimers: studies in experimental immune thrombocytopenia. Blood (2001) 1.17
Application of germline IGH probes in real-time quantitative PCR for the detection of minimal residual disease in acute lymphoblastic leukemia. Leukemia (2000) 1.14
The IgM-associated protein mb-1 as a marker of normal and neoplastic B cells. J Immunol (1991) 1.12
Beta1 integrin activation on human neutrophils promotes beta2 integrin-mediated adhesion to fibronectin. Eur J Immunol (2001) 1.12
Human bone marrow cells positive for terminal deoxynucleotidyl transferase (TdT), HLA-DR, and a T cell marker may represent prothymocytes. J Immunol (1985) 1.11
Early stages in the development of human T, natural killer and thymic dendritic cells. Immunol Rev (1998) 1.09
Evidence for small intracellular vesicles in human blood phagocytes containing cytochrome b558 and the adhesion molecule CD11b/CD18. Blood (1993) 1.09
Disruption of alpha beta but not of gamma delta T cell development by overexpression of the helix-loop-helix protein Id3 in committed T cell progenitors. EMBO J (1999) 1.09
The B29 and mb-1 polypeptides are differentially expressed during human B cell differentiation. Eur J Immunol (1992) 1.07
Genomic organization, splice variants and expression of CGM1, a CD66-related member of the carcinoembryonic antigen gene family. Eur J Biochem (1993) 1.07
Characterization of ABF-1, a novel basic helix-loop-helix transcription factor expressed in activated B lymphocytes. Mol Cell Biol (1998) 1.07
Sustained activation of neutrophils in the course of Kawasaki disease: an association with matrix metalloproteinases. Clin Exp Immunol (2005) 1.07
Therapies in Aicardi-Goutières syndrome. Clin Exp Immunol (2014) 1.07
Reviewing Omenn syndrome. Eur J Pediatr (2001) 1.07
Divergent effects of tumor necrosis factor alpha on apoptosis of human neutrophils. J Leukoc Biol (2001) 1.06
T cell receptor-CD3 complex during early T cell differentiation. Analysis of immature T cell acute lymphoblastic leukemias (T-ALL) at DNA, RNA, and cell membrane level. J Immunol (1987) 1.06
Longitudinal survey of lymphocyte subpopulations in the first year of life. Pediatr Res (2000) 1.05
Comparison of different polymerase chain reaction-based approaches for clonality assessment of immunoglobulin heavy-chain gene rearrangements in B-cell neoplasia. Mod Pathol (1999) 1.05
Vasoactive side effects of intravenous immunoglobulin preparations in a rat model and their treatment with recombinant platelet-activating factor acetylhydrolase. Blood (2000) 1.04
Multiple rearranged immunoglobulin genes in childhood acute lymphoblastic leukemia of precursor B-cell origin. Leukemia (1991) 1.03
Cytolytic mechanisms and expression of activation-regulating receptors on effector-type CD8+CD45RA+CD27- human T cells. J Immunol (2000) 1.02
Genetic variation in ICF syndrome: evidence for genetic heterogeneity. Hum Mutat (2000) 1.01
Oligoclonal gammopathy in phenotypic diarrhea. J Pediatr Gastroenterol Nutr (2000) 1.01
High prevalence of mannose-binding lectin (MBL) deficiency in premature neonates. Clin Exp Immunol (2006) 0.99
Phenotype of blood monocytes and alveolar macrophages in interstitial lung disease. Chest (1989) 0.98
Ordered recombination of immunoglobulin light chain genes occurs at the IGK locus but seems less strict at the IGL locus. Blood (2001) 0.98
Human T cell leukemias with continuous V(D)J recombinase activity for TCR-delta gene deletion. J Immunol (1997) 0.97
T cell receptor gamma (TCRG) gene rearrangements in T cell acute lymphoblastic leukemia refelct 'end-stage' recombinations: implications for minimal residual disease monitoring. Leukemia (2000) 0.97
Granulocyte transfusions in neutropaenic children: a systematic review of the literature. Eur J Cancer (2007) 0.97
Southern blot patterns, frequencies, and junctional diversity of T-cell receptor-delta gene rearrangements in acute lymphoblastic leukemia. Blood (1993) 0.95
Regenerating normal B-cell precursors during and after treatment of acute lymphoblastic leukaemia: implications for monitoring of minimal residual disease. Br J Haematol (2000) 0.95
BTKbase, mutation database for X-linked agammaglobulinemia (XLA). Nucleic Acids Res (1998) 0.94
Low mannose-binding lectin (MBL) levels in neonates with pneumonia and sepsis. Clin Exp Immunol (2007) 0.94
Localization of the ICF syndrome to chromosome 20 by homozygosity mapping. Am J Hum Genet (1998) 0.94
Molecular features responsible for the absence of immunoglobulin heavy chain protein synthesis in an IgH(-) subgroup of multiple myeloma. Blood (2000) 0.94
The role of mannose-binding lectin (MBL) in paediatric oncology patients with febrile neutropenia. Eur J Cancer (2006) 0.94
BMA031, a monoclonal antibody suited to identify the T-cell receptor alpha beta/CD3 complex on viable human T lymphocytes in normal and disease states. Hum Immunol (1990) 0.94
Analysis of T cell receptor-gene rearrangement in T cells from the cerebrospinal fluid of patients with multiple sclerosis. J Neuroimmunol (1987) 0.93
Expression of a human homing receptor (CD44) in lymphoid malignancies and related stages of lymphoid development. Leukemia (1990) 0.93
Real-time quantitative PCR for detection of minimal residual disease before allogeneic stem cell transplantation predicts outcome in children with acute lymphoblastic leukemia. Leukemia (2001) 0.93
Intramitochondrial serine protease activity of Omi/HtrA2 is required for caspase-independent cell death of human neutrophils. Cell Death Differ (2004) 0.92
Heterogeneity in junctional regions of immunoglobulin kappa deleting element rearrangements in B cell leukemias: a new molecular target for detection of minimal residual disease. Leukemia (1997) 0.92
Mitochondria in neutrophil apoptosis. Int J Hematol (2006) 0.92
Basic helix-loop-helix proteins E2A and HEB induce immature T-cell receptor rearrangements in nonlymphoid cells. Blood (2001) 0.92
N-terminal truncated human RAG1 proteins can direct T-cell receptor but not immunoglobulin gene rearrangements. Blood (2000) 0.92
Richter's syndrome with different immunoglobulin light chains and different heavy chain gene rearrangements. Blood (1984) 0.92
Detection of T cell receptor beta (TCRB) gene rearrangement patterns in T cell malignancies by Southern blot analysis. Leukemia (1999) 0.91
Extensive junctional diversity of gamma delta T-cell receptors expressed by T-cell acute lymphoblastic leukemias: implications for the detection of minimal residual disease. Leukemia (1991) 0.91
Polymorphisms in chemokine receptor genes and susceptibility to Kawasaki disease. Clin Exp Immunol (2007) 0.91
Translocation (6;9) may be associated with a specific TdT-positive immunological phenotype in ANLL. Leukemia (1988) 0.91
Intracellular events in anti-IgE nonreleasing human basophils. J Allergy Clin Immunol (1992) 0.91
Immunophenotypic changes between diagnosis and relapse in childhood acute lymphoblastic leukemia. Leukemia (1995) 0.90
tal-1 deletions in T-cell acute lymphoblastic leukemia as PCR target for detection of minimal residual disease. Leukemia (1993) 0.90
Polarized secretion of interleukin-8 by human mesothelial cells: a role in neutrophil migration. Immunology (1995) 0.90